Drug updated on 11/15/2023

Dosage FormInjection (intravenous: 1 mg/mL, 2 mg/2 mL, 30 mg/30 mL)
Drug ClassOpioid agonists
Ongoing and Completed StudiesClinicalTrials.gov


  • For the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate.

Product Monograph / Prescribing Information

Document TitleYearSource
Olinvyk (oliceridine) Prescribing Information.2021Trevena, Inc., Chesterbrook, PA

Systematic Reviews / Meta-Analyses